IN2014MN01809A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN01809A IN2014MN01809A IN1809MUN2014A IN2014MN01809A IN 2014MN01809 A IN2014MN01809 A IN 2014MN01809A IN 1809MUN2014 A IN1809MUN2014 A IN 1809MUN2014A IN 2014MN01809 A IN2014MN01809 A IN 2014MN01809A
- Authority
- IN
- India
- Prior art keywords
- features
- evaluating
- test results
- gastrointestinal cancer
- target individual
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261641979P | 2012-05-03 | 2012-05-03 | |
| PCT/IL2013/050368 WO2013164823A1 (en) | 2012-05-03 | 2013-05-02 | Methods and systems of evaluating a risk of a gastrointestinal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01809A true IN2014MN01809A (de) | 2015-07-03 |
Family
ID=49514271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1809MUN2014 IN2014MN01809A (de) | 2012-05-03 | 2013-05-02 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US9474490B2 (de) |
| EP (1) | EP2844131B1 (de) |
| JP (1) | JP6267687B2 (de) |
| KR (1) | KR102094326B1 (de) |
| CN (1) | CN104271033B (de) |
| AU (1) | AU2013255401B2 (de) |
| CA (1) | CA2865892C (de) |
| ES (1) | ES2655184T3 (de) |
| HK (1) | HK1205448A1 (de) |
| IN (1) | IN2014MN01809A (de) |
| MX (1) | MX347850B (de) |
| PL (1) | PL2844131T3 (de) |
| RU (1) | RU2640568C2 (de) |
| WO (1) | WO2013164823A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX347850B (es) | 2012-05-03 | 2017-05-16 | Medial Res Ltd | Métodos y sistemas para evaluar un riesgo de un cáncer gastrointestinal. |
| WO2015195642A1 (en) * | 2014-06-16 | 2015-12-23 | Siemens Healthcare Diagnostics Inc. | Analyzing digital holographic microscopy data for hematology applications |
| US10614287B2 (en) | 2014-06-16 | 2020-04-07 | Siemens Healthcare Diagnostics Inc. | Virtual staining of cells in digital holographic microscopy images using general adversarial networks |
| US20160110516A1 (en) * | 2014-10-20 | 2016-04-21 | Liwei Ma | Dynamic monitoring early cancer risk |
| CN104573410A (zh) * | 2015-01-20 | 2015-04-29 | 合肥工业大学 | 基于分子子网与随机森林分类器的癌症化疗敏感性预测方法 |
| CN104615894B (zh) * | 2015-02-13 | 2018-09-28 | 上海中医药大学 | 一种基于k近邻标签特定权重特征的中医诊断系统 |
| CN106339569B (zh) * | 2015-07-09 | 2021-01-05 | 深圳迈瑞生物医疗电子股份有限公司 | 判断样本检验结果异常的方法及装置 |
| WO2017015234A1 (en) * | 2015-07-17 | 2017-01-26 | Albert Joseph Swiston | Methods and systems for pre-symptomatic detection of exposure to an agent |
| JP6100867B1 (ja) * | 2015-11-06 | 2017-03-22 | 振武 曽 | 免疫状態の分析のための検査方法 |
| US20190148019A1 (en) * | 2016-05-12 | 2019-05-16 | Hoffmann-La Roche Inc. | System for predicting efficacy of a target-directed drug to treat a disease |
| US20180000428A1 (en) * | 2016-05-18 | 2018-01-04 | Massachusetts Institute Of Technology | Methods and Systems for Pre-Symptomatic Detection of Exposure to an Agent |
| KR101747783B1 (ko) * | 2016-11-09 | 2017-06-15 | (주) 바이오인프라생명과학 | 특정 항목이 속하는 클래스를 예측하기 위한 2-클래스 분류 방법 및 이를 이용하는 컴퓨팅 장치 |
| US20170140115A1 (en) * | 2017-01-24 | 2017-05-18 | Liwei Ma | Intelligent stroke risk prediction and monitoring system |
| US20170147768A1 (en) * | 2017-02-06 | 2017-05-25 | Liwei Ma | System and method for detecting and monitoring acute myocardial infarction risk |
| US20210249136A1 (en) * | 2018-08-17 | 2021-08-12 | The Regents Of The University Of California | Diagnosing hypoadrenocorticism from hematologic and serum chemistry parameters using machine learning algorithm |
| CN109670526A (zh) * | 2018-11-09 | 2019-04-23 | 全球能源互联网研究院有限公司 | 一种电网的干扰源类型辨识方法、装置、设备及存储介质 |
| US20220165362A1 (en) * | 2019-03-28 | 2022-05-26 | Hoffmann-La Roche Inc. | Cancer prognosis |
| US20210299339A1 (en) * | 2020-03-31 | 2021-09-30 | Fresenius Medical Care Holdings, Inc. | Blood monitoring system for determining a calibrated hemoglobin concentration value for a patient based on patient-specific mean corpuscular hemoglobin concentration data |
| TWI763215B (zh) * | 2020-12-29 | 2022-05-01 | 財團法人國家衛生研究院 | 篩選用於預測生理狀態的特徵的電子裝置和方法 |
| CN112735606B (zh) * | 2021-01-22 | 2023-04-25 | 张厚德 | 结直肠癌风险预测方法、设备及存储介质 |
| CN112908470B (zh) * | 2021-02-08 | 2023-10-03 | 深圳市人民医院 | 一种基于rna结合蛋白基因的肝细胞癌预后评分系统及其应用 |
| CN112986446A (zh) * | 2021-04-19 | 2021-06-18 | 生态环境部华南环境科学研究所 | 禽蛋类产品中有机磷酸酯及代谢物的同步检测方法及应用 |
| GB202109560D0 (en) * | 2021-07-01 | 2021-08-18 | Chancellor Masters And Scholars Of The Univ Of Cambridge | Anomaly detection based on complete blood counts |
| WO2023147472A1 (en) * | 2022-01-28 | 2023-08-03 | Freenome Holdings, Inc. | Methods and systems for risk stratification of colorectal cancer |
| CN115620909B (zh) * | 2022-11-04 | 2023-08-04 | 内蒙古卫数数据科技有限公司 | 一种基于全血细胞计数融合指标hbi的癌症风险评估系统 |
| CN117524464B (zh) * | 2024-01-04 | 2024-04-05 | 北京和兴创联健康科技有限公司 | 一种基于大数据的计算手术后目标血红蛋白的方法及系统 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5692220A (en) | 1993-09-02 | 1997-11-25 | Coulter Corporation | Decision support system and method for diagnosis consultation in laboratory hematopathology |
| US6059724A (en) | 1997-02-14 | 2000-05-09 | Biosignal, Inc. | System for predicting future health |
| US6881548B2 (en) | 1997-05-23 | 2005-04-19 | A&G Pharmaceutical, Inc. | Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| US7838296B2 (en) | 2002-08-28 | 2010-11-23 | Separation Technology, Inc. | Methods and apparatus for ultrasonic determination of red blood cell indices |
| US20040122703A1 (en) * | 2002-12-19 | 2004-06-24 | Walker Matthew J. | Medical data operating model development system and method |
| US7951078B2 (en) | 2005-02-03 | 2011-05-31 | Maren Theresa Scheuner | Method and apparatus for determining familial risk of disease |
| WO2006102526A2 (en) | 2005-03-22 | 2006-09-28 | Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Identification of biomarkers by serum protein profiling |
| US20090150315A1 (en) * | 2005-07-29 | 2009-06-11 | Siemens Healthcare Diagnostics Inc. | Neoplastic Disease-Related Methods, Kits, Systems and Databases |
| JP5746811B2 (ja) * | 2006-12-21 | 2015-07-08 | 味の素株式会社 | 大腸癌の評価方法、ならびに大腸癌評価装置、大腸癌評価方法、大腸癌評価システム、大腸癌評価プログラムおよび記録媒体 |
| JP5025371B2 (ja) * | 2007-07-31 | 2012-09-12 | シスメックス株式会社 | 血液分析装置 |
| US8512240B1 (en) * | 2007-11-14 | 2013-08-20 | Medasense Biometrics Ltd. | System and method for pain monitoring using a multidimensional analysis of physiological signals |
| US20100076787A1 (en) * | 2008-09-11 | 2010-03-25 | Stephen Naylor | Method for preparing a medical data report |
| NZ592241A (en) | 2008-09-15 | 2012-11-30 | Herlev Hospital | Ykl-40 as a marker for gastrointestinal cancers |
| WO2010048282A1 (en) | 2008-10-21 | 2010-04-29 | Rothman Healthcare Research, Llc | Methods of assessing risk based on medical data and uses thereof |
| GB2463401B (en) | 2008-11-12 | 2014-01-29 | Caris Life Sciences Luxembourg Holdings S A R L | Characterizing prostate disorders by analysis of microvesicles |
| WO2011060098A1 (en) | 2009-11-10 | 2011-05-19 | Prometheus Laboratories Inc. | Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis |
| WO2011063389A2 (en) | 2009-11-23 | 2011-05-26 | Children's Medical Center Corporation | Normalization of platelet biomarkers |
| MX347850B (es) | 2012-05-03 | 2017-05-16 | Medial Res Ltd | Métodos y sistemas para evaluar un riesgo de un cáncer gastrointestinal. |
-
2013
- 2013-05-02 MX MX2014011202A patent/MX347850B/es active IP Right Grant
- 2013-05-02 US US14/347,245 patent/US9474490B2/en active Active
- 2013-05-02 JP JP2015509566A patent/JP6267687B2/ja active Active
- 2013-05-02 PL PL13784595T patent/PL2844131T3/pl unknown
- 2013-05-02 ES ES13784595.4T patent/ES2655184T3/es active Active
- 2013-05-02 WO PCT/IL2013/050368 patent/WO2013164823A1/en active Application Filing
- 2013-05-02 KR KR1020147026479A patent/KR102094326B1/ko active IP Right Grant
- 2013-05-02 CN CN201380022626.6A patent/CN104271033B/zh active Active
- 2013-05-02 IN IN1809MUN2014 patent/IN2014MN01809A/en unknown
- 2013-05-02 EP EP13784595.4A patent/EP2844131B1/de active Active
- 2013-05-02 AU AU2013255401A patent/AU2013255401B2/en active Active
- 2013-05-02 CA CA2865892A patent/CA2865892C/en active Active
- 2013-05-02 RU RU2014140114A patent/RU2640568C2/ru active
-
2015
- 2015-06-25 HK HK15106039.3A patent/HK1205448A1/xx unknown
-
2016
- 2016-10-20 US US15/298,372 patent/US10452970B2/en active Active
-
2019
- 2019-10-20 US US16/658,087 patent/US11651189B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20170039334A1 (en) | 2017-02-09 |
| EP2844131A4 (de) | 2015-11-18 |
| US9474490B2 (en) | 2016-10-25 |
| US11651189B2 (en) | 2023-05-16 |
| CA2865892C (en) | 2021-08-24 |
| RU2014140114A (ru) | 2016-06-20 |
| ES2655184T3 (es) | 2018-02-19 |
| EP2844131B1 (de) | 2017-10-11 |
| EP2844131A1 (de) | 2015-03-11 |
| HK1205448A1 (en) | 2015-12-18 |
| KR20150005909A (ko) | 2015-01-15 |
| US20140235956A1 (en) | 2014-08-21 |
| US20200050917A1 (en) | 2020-02-13 |
| PL2844131T3 (pl) | 2018-03-30 |
| AU2013255401A1 (en) | 2014-09-18 |
| AU2013255401B2 (en) | 2017-02-23 |
| CN104271033A (zh) | 2015-01-07 |
| JP6267687B2 (ja) | 2018-01-24 |
| JP2015517653A (ja) | 2015-06-22 |
| MX2014011202A (es) | 2014-11-21 |
| KR102094326B1 (ko) | 2020-03-30 |
| RU2640568C2 (ru) | 2018-01-09 |
| MX347850B (es) | 2017-05-16 |
| CN104271033B (zh) | 2017-05-24 |
| WO2013164823A1 (en) | 2013-11-07 |
| CA2865892A1 (en) | 2013-11-07 |
| US10452970B2 (en) | 2019-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01809A (de) | ||
| MX2016005825A (es) | Procedimientos y sistemas para evaluar un riesgo de cancer de pulmon. | |
| HK1257999A1 (zh) | 用於臨床應用的分析物收集、提取、濃縮和檢測的方法和裝置 | |
| IL244852A0 (en) | Analysis and monitoring of clinical outcome | |
| EP3598116A4 (de) | Röntgenfluoreszenzanalyseverfahren, röntgenfluoreszenzanalyseprogramm und röntgenfluoreszenzspektrometer | |
| EP2973121A4 (de) | Systeme und verfahren zur analyse und meldung von mit krankheiten assoziierten varianten des menschlichen genoms | |
| MX2014002008A (es) | Aparato de procesamiento de informacion, metodo de procesamiento de informacion, programa, y sistema de procesamiento de informacion. | |
| PH12014502436A1 (en) | In vitro method for the diagnosis and surveillance of cancer | |
| WO2015189174A3 (en) | Improved frequency-domain interferometric based imaging systems and methods | |
| EP2863309A3 (de) | Kontextuelle Graphanpassung basierend auf Anomaliedetektion | |
| WO2015094995A3 (en) | Gene signature biomarkers of tumor response to pd-1 antagonists | |
| EP2881465A4 (de) | An eine etikettabfolge angehängte zweidimensionale cdns-bibliothek sowie genexpressionsanalyseverfahren und genexpressionsanalysevorrichtung damit | |
| EP2975631A4 (de) | Ladungsträgerstrahlvorrichtung, probenbeobachtungsverfahren, probenplattform, beobachtungssystem und lichtemittierendes element | |
| EP2688063A3 (de) | Tonfolgeanalyseverfahren | |
| MX2016004865A (es) | Metodo y dispositivo para analizar relacion social. | |
| MX2013000776A (es) | Sistemas y metodos para analizar un miembro en forma de peine de tiras de prueba de inmunoensayo. | |
| EP3353354A4 (de) | Stuhlprobensammel-, abtast- und diagnosemittel und verfahren dafür | |
| WO2015049289A3 (en) | Breast cancer diagnostic method and means | |
| WO2015094996A3 (en) | Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists | |
| EP2639604A3 (de) | Verfahren und System zur Präsentation eines Druckbereichs | |
| GB2516329A (en) | Method of electron beam diffraction analysis | |
| EP2607913A3 (de) | Magneteigenschaften-Analysierverfahren und -vorrichtung | |
| EP2720217A3 (de) | Verfahren zur Ableitung des Schwungergebnisses und Haltungskorrektur und Vorrichtung dafür | |
| WO2015153948A3 (en) | Microtentacle imaging in patient tumor samples | |
| HK1258233A1 (zh) | 包括根據每個細胞產生的光譜對細胞識別或分類的用於分析樣本的方法、計算機程序和系統 |